About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

KAINOS Laboratories,Inc.(4556) Summary

4556
TSE Standard
KAINOS Laboratories,Inc.
1,155
JPY
+15
(+1.32%)
Apr 11, 3:15 pm JST
8.02
USD
Apr 11, 2:15 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
8.8
PBR
0.73
Yield
3.03%
Margin Trading Ratio
Stock Price
Apr 11, 2025
Opening Apr 11, 9:00 am
1,140 JPY 7.93 USD
Previous Close Apr 10
1,140 JPY 7.76 USD
High Apr 11, 9:00 am
1,165 JPY 8.10 USD
Low Apr 11, 9:00 am
1,140 JPY 7.92 USD
Volume
3,600
Trading Value
4.00M JPY 0.03M USD
VWAP
1144.47 JPY 7.95 USD
Minimum Trading Value
115,500 JPY 802 USD
Market Cap
5.27B JPY 0.04B USD
Number of Trades
16
Liquidity & Number of Trades
As of Apr 11, 2025
Liquidity
Slightly Low
1-Year Average
25
1-Year High Jul 25, 2024
664
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 4, 2025 0 47,800
Mar 28, 2025 0 55,300
Mar 21, 2025 0 50,900
Mar 14, 2025 0 50,900
Mar 7, 2025 0 52,000
Company Profile
KAINOS Laboratories, Inc. is a mid-tier clinical diagnostics company specializing in renal function and allergy tests, with a focus on biochemistry and immunoserology.
Sector
Pharmaceuticals
KAINOS Laboratories, Inc. primarily engages in the manufacture and sale of in vitro diagnostic reagents and medical devices for clinical testing. The company operates independently without subsidiaries or affiliates, maintaining a continuous and close business relationship with Asahi Kasei Pharma. In the field of clinical diagnostics, KAINOS's main products include those for renal function and blood transfusion tests. The company particularly excels in biochemical and immunoserological testing, demonstrating its strengths in these areas. By providing essential products for diagnosis and treatment decisions in medical settings, KAINOS contributes to improving the quality of healthcare.